Webinars

Learning Outcomes

Tuesday 2nd September 2025 ‘Identifying risk, ongoing monitoring & standard care processes for adults with Type 2 Diabetes’ Please note this session will be held at 12pm-1pm

• To be confident in identifying those people who are at risk of type 2 diabetes
• To be confident in determining an accurate diagnosis of type 2 diabetes
• To be aware of the standards of care for type 2 diabetes
• To identify the various methods required for the monitoring of type 2 diabetes

Tuesday 4th November 2025 ‘The Self-Care Challenge; supporting people with long term conditions’

• To understand how adopting a patient-centered approach can support people with effective self-management and change
• To explore the potential conversational structure, language, and tools that promote motivation, self-management and change
• To understand the Stages of Change model
• To reflect on the best way to support patients with long-term conditions

Wednesday 17th December 2025 ‘Therapy Choices for adults with Type 2 Diabetes (Part A)’

• Discuss the considerations when choosing a treatment to meet the needs and circumstances of individual adult patients with type 2 diabetes
• Review the standard oral therapies used in the treatment of type 2 diabetes: metformin, sulphonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and oral GLP-1 RAs
• Understand the sites of action for the different oral drug classes and be aware of the prescribing considerations including renal function and hepatic disease
• Recognise the need to consider therapy specific factors and the individual patient’s circumstances when choosing between different oral therapies

Tuesday 20^th January 2026 ‘Therapy Choices for adults with Type 2 Diabetes (Part B)’

• Discuss the considerations when choosing a treatment to meet the needs and circumstances of individual adult patients with type 2 diabetes
• Review the standard oral therapies used in the treatment of type 2 diabetes: metformin, sulphonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and oral GLP-1 RAs
• Understand the sites of action for the different oral drug classes and be aware of the prescribing considerations including renal function and hepatic disease
• Recognise the need to consider therapy specific factors and the individual patient’s circumstances when choosing between different oral therapies

Tuesday 3^rd February 2026 ‘Younger Adults with Type 2 Diabetes’

• The growing problem of type 2 diabetes (T2D) in younger adults
• The importance of early identification and management
• Psychosocial considerations in younger adults with T2D
• Holistic approach to care in younger adults with T2D

Tuesday 24^th March 2026 ‘Understanding Incretin Hormones & their role in the management of adults with Type 2 Diabetes’

• To understand the role of the incretin hormones, native GLP-1 and GIP, in humans
• To discuss the effects of incretin-based therapy in people with T2D and its position in the treatment pathway
• To review important considerations of risk management in diabetes

Wednesday 29^th April 2026 ‘Why Weight Matters in Type 2 Diabetes’

• To understand the links between weight & Type 2 diabetes and the impact of Type 2 Diabetes on people living with overweight/obesity
• To review the pathophysiology of Type 2 diabetes in people living with overweight and obesity
• To recognise the importance and challenges of weight management in people with Type 2 Diabetes
• To explore ways to support people in achieving their treatment and weight management goals

Wednesday 10^th June 2026 (TBC)